Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom M Quinn

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Interventions in Aging|September 22, 2018
Non-cystic fibrosis bronchiectasis in the elderly: current perspectivesTom M Quinn, Adam T Hill
BMC Pulmonary Medicine|August 29, 2024
Phase 0 trials/ Intra-Target-Microdosing (ITM) and the lung: a reviewTom M Quinn, Annya M Bruce, Tal Burt, et al.
Chest|October 11, 2016
Bronchiectasis Severity Is an Independent Risk Factor for Vascular Disease in a Bronchiectasis CohortIeuan Edward Shepherd Evans, Pallavi Bedi, Tom M Quinn, et al.
Frontiers in Immunology|February 27, 2023
Specific <i>in situ</i> immuno-imaging of pulmonary-resident memory lymphocytes in human lungsDuncan C Humphries, Richard A O'Connor, Hazel L Stewart, et al.
BMC Infectious Diseases|May 15, 2023
Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in DelhiBharti Wadhwa, Vikas Malhotra, Sukhyanti Kerai, et al.
American Journal of Respiratory and Critical Care Medicine|August 16, 2022
An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE)Erin E Gaughan, Tom M Quinn, Andrew Mills, et al.
Ebiomedicine|February 13, 2022
Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and PharmacodynamicsTom M Quinn, Erin E Gaughan, Annya Bruce, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Interventions in Aging|September 22, 2018
Non-cystic fibrosis bronchiectasis in the elderly: current perspectivesTom M Quinn, Adam T Hill
BMC Pulmonary Medicine|August 29, 2024
Phase 0 trials/ Intra-Target-Microdosing (ITM) and the lung: a reviewTom M Quinn, Annya M Bruce, Tal Burt, et al.
Chest|October 11, 2016
Bronchiectasis Severity Is an Independent Risk Factor for Vascular Disease in a Bronchiectasis CohortIeuan Edward Shepherd Evans, Pallavi Bedi, Tom M Quinn, et al.
Frontiers in Immunology|February 27, 2023
Specific <i>in situ</i> immuno-imaging of pulmonary-resident memory lymphocytes in human lungsDuncan C Humphries, Richard A O'Connor, Hazel L Stewart, et al.
BMC Infectious Diseases|May 15, 2023
Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in DelhiBharti Wadhwa, Vikas Malhotra, Sukhyanti Kerai, et al.
American Journal of Respiratory and Critical Care Medicine|August 16, 2022
An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE)Erin E Gaughan, Tom M Quinn, Andrew Mills, et al.
Ebiomedicine|February 13, 2022
Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and PharmacodynamicsTom M Quinn, Erin E Gaughan, Annya Bruce, et al.
Pageof 1